NICE backs digital CBT apps for youngsters with anxiety

Draft guidance in the UK has provisionally recommended that digital cognitive behavioural therapy (CBT) apps can be used within the NHS to treat children and young people with mild to moder

Innovative Medicines Fund and the opportunity for ICSs to mo...

NICE says yes to Grifols' Tavlesse for rare blood disorder I...

Patients across the UK with chronic immune thrombocytopenia (ITP) now have another treatment option, after NICE backed use of Spanish drugmaker Grifols' Tavlesse for adults with the rare bl

Wellcome funds work on regulating digital mental health tool...

An explosion of digital mental health tools being offered for sale has presented regulators with a problem – how should they be classified and assessed for safety or efficacy?

Translarna not approved by NICE for DMD on NHS

In draft guidance published on Friday, it emerged NICE does not recommend PTC Therapeutics’ Translarna (ataluren) for the treatment of Duchenne muscular dystrophy (DMD) caused by a nonsense

NICE backs 'real-world' wearable devices for Parkinson's dis...

Five wearable devices that monitor patients with Parkinson's disease as they go about their lives have been given a provisional recommendation from NICE, making them available via the NHS w